Guobang Pharma Ltd. (SHA:605507)
China · Delayed Price · Currency is CNY 15.58
+0.19 (1.23%)
Sep 4, 2026, 3:00 PM CST
Guobang Pharma Market Cap
Guobang Pharma has a market cap or net worth of 12.03 billion as of September 4, 2026. Its market cap has decreased by -5.47% in one year.
Market Cap
12.03B
Enterprise Value
10.54B
Revenue
6.13B
Ranking
n/a
PE Ratio
17.01
Stock Price
15.58
ChartMarket Cap Chart
Since August 2, 2021, Guobang Pharma's market cap has decreased from 26.21B to 12.03B, a decrease of -54.11%. That is a compound annual growth rate of -14.18%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 4, 2026 | 12.03B | -12.30% |
| Dec 31, 2025 | 13.71B | 19.12% |
| Dec 31, 2024 | 11.51B | 17.32% |
| Dec 29, 2023 | 9.81B | -33.66% |
| Dec 30, 2022 | 14.79B | -8.19% |
| Dec 31, 2021 | 16.11B | -38.53% |
| Aug 2, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Zhejiang Jiuzhou Pharmaceutical | 13.26B |
| Shenzhen Hepalink Pharmaceutical Group | 13.14B |
| Nanjing King-Friend Biochemical Pharmaceutical | 12.75B |
| Tibet Rhodiola Pharmaceutical Holding Co. | 12.12B |
| Wedge Industrial | 12.02B |
| Zhejiang Medicine | 12.02B |
| Shanghai Shyndec Pharmaceutical | 11.39B |
| Shenzhen Chipscreen Biosciences | 11.19B |